Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-06

Clinical Trial Update: Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on anastrozole for preventing breast cancer in postmenopausal women at increased risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED